Change in patient‐centered outcomes of psychological well‐being, sleep, and suicidality following treatment with intravenous ketamine for late‐life treatment‐resistant depression
International Journal of Geriatric Psychiatry July 1, 2023 Benjamin Vanderschelden, M. A. Gebara, H. Oughli et al. 13 citations
To examine whether psychological well‐being, sleep, and suicidality improved with treatment with intravenous (IV) ketamine for late‐life treatment‐resistant depression (TRD).